{"altmetric_id":24592814,"counts":{"readers":{"mendeley":1,"citeulike":0,"connotea":0},"total":{"posts_count":12},"blogs":{"unique_users_count":1,"unique_users":[57719],"posts_count":1},"twitter":{"unique_users_count":9,"unique_users":["amit_sharma_ind","ProfSKrishna","Structure_CP","dkubhi","kfreybiochem","MalariaPapers","NDM_Papers","OxDrugDes","vituljain"],"posts_count":10},"facebook":{"unique_users_count":1,"unique_users":["100549596713047"],"posts_count":1}},"selected_quotes":["Vitul and Yoga's tour de force - international teams - validation of STOPP","Prolyl-tRNA Synthetase inhibitors as potential #antibiotics.","Quinazolinone-based molecules selectively inhibit prolyl-tRNA synthetase in parasites and can clear malaria","Targeting Prolyl-tRNA Synthetase to Accelerate Drug Discovery against Malaria, Leishmaniasis, Toxoplasmosis,\u2026","Targeting Prolyl-tRNA Synthetase to Accelerate Drug Discovery against Malaria, Leishmaniasis, Toxoplasmosis, Crypt\u2026"],"citation":{"abstract":"Developing anti-parasitic lead compounds that act\u00a0on key vulnerabilities are necessary for new anti-infectives. Malaria, leishmaniasis, toxoplasmosis, cryptosporidiosis and coccidiosis together kill >500,000 humans annually. Their causative parasites Plasmodium, Leishmania, Toxoplasma, Cryptosporidium and Eimeria display high conservation in many housekeeping genes, suggesting that these parasites can be attacked by targeting invariant essential proteins. Here, we describe selective and potent inhibition of prolyl-tRNA synthetases (PRSs) from the above parasites using a\u00a0series\u00a0of quinazolinone-scaffold compounds. Our\u00a0PRS-drug co-crystal structures reveal remarkable active\u00a0site plasticity that accommodates diversely substituted compounds, an enzymatic feature that can be leveraged for refining drug-like properties of quinazolinones on a per parasite basis. A compound we termed In-5 exhibited a unique double conformation, enhanced drug-like properties, and cleared malaria in mice. It thus represents a new lead for optimization. Collectively, our data offer insights into the\u00a0structure-guided optimization of\u00a0quinazolinone-based compounds for drug development against multiple human eukaryotic pathogens.","altmetric_jid":"4f6fa5143cf058f6100035d2","authors":["Jain, Vitul","Yogavel, Manickam","Kikuchi, Haruhisa","Oshima, Yoshiteru","Hariguchi, Norimitsu","Matsumoto, Makoto","Goel, Preeti","Touquet, Bastien","Jumani, Rajiv S.","Tacchini-Cottier, Fabienne","Harlos, Karl","Huston, Christopher D.","Hakimi, Mohamed-Ali","Sharma, Amit","Vitul Jain","Manickam Yogavel","Haruhisa Kikuchi","Yoshiteru Oshima","Norimitsu Hariguchi","Makoto Matsumoto","Preeti Goel","Bastien Touquet","Rajiv S. Jumani","Fabienne Tacchini-Cottier","Karl Harlos","Christopher D. Huston","Mohamed-Ali Hakimi","Amit Sharma"],"doi":"10.1016\/j.str.2017.07.015","first_seen_on":"2017-09-01T02:49:41+00:00","funders":["niehs"],"handles":[],"issns":["0969-2126","09692126","1878-4186"],"journal":"Structure","last_mentioned_on":1505942225,"links":["http:\/\/www.cell.com\/structure\/fulltext\/S0969-2126(17)30249-6","https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28867614?dopt=Abstract","https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28867614?dopt=Abstract&utm_source=dlvr.it&utm_medium=twitter","https:\/\/doi.org\/10.1016\/j.str.2017.07.015","http:\/\/www.cell.com\/structure\/abstract\/S0969-2126(17)30249-6","http:\/\/www.cell.com\/structure\/fulltext\/S0969-2126(17)30249-6?_returnURL=http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969212617302496?showall=true#.Wa_mNuD5vUo.facebook","http:\/\/www.cell.com\/structure\/fulltext\/S0969-2126%2817%2930249-6#.WbvIMXM6vrM.twitter"],"pmid":"28867614","pubdate":"2017-08-01T00:00:00+00:00","publisher":"Elsevier BV","publisher_subjects":[{"name":"Biological Sciences","scheme":"era"},{"name":"Information And Computing Sciences","scheme":"era"},{"name":"Chemical Sciences","scheme":"era"}],"scopus_subjects":["Life Sciences","Biochemistry, Genetics and Molecular Biology"],"subjects":["molecularbiology","biotechnology","biochemistry"],"title":"Targeting Prolyl-tRNA Synthetase to Accelerate Drug Discovery against Malaria, Leishmaniasis, Toxoplasmosis, Cryptosporidiosis, and Coccidiosis","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/targeting-prolyltrna-synthetase-accelerate-drug-discovery-against-malaria-leishmaniasis-toxoplasmosi"},"altmetric_score":{"score":14.558,"score_history":{"1y":14.558,"6m":14.558,"3m":14.558,"1m":14.558,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":14.558},"context_for_score":{"all":{"total_number_of_other_articles":8440508,"mean":7.0976499018281,"rank":605058,"this_scored_higher_than_pct":92,"this_scored_higher_than":7835507,"rank_type":"exact","sample_size":8440508,"percentile":92},"similar_age_3m":{"total_number_of_other_articles":165237,"mean":12.390887373212,"rank":19069,"this_scored_higher_than_pct":88,"this_scored_higher_than":146168,"rank_type":"exact","sample_size":165237,"percentile":88},"this_journal":{"total_number_of_other_articles":1906,"mean":4.6437207349081,"rank":84,"this_scored_higher_than_pct":95,"this_scored_higher_than":1822,"rank_type":"exact","sample_size":1906,"percentile":95},"similar_age_this_journal_3m":{"total_number_of_other_articles":31,"mean":9.1726666666667,"rank":4,"this_scored_higher_than_pct":87,"this_scored_higher_than":27,"rank_type":"exact","sample_size":31,"percentile":87}}},"demographics":{"poster_types":{"member_of_the_public":5,"researcher":3,"science_communicator":1},"users":{"twitter":{"cohorts":{"Members of the public":5,"Scientists":3,"Science communicators (journalists, bloggers, editors)":1}},"mendeley":{"by_status":{"Student  > Ph. D. Student":1},"by_discipline":{"Chemistry":1}}},"geo":{"twitter":{"IN":1,"US":2,"GB":2}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/amit_sharma_ind\/statuses\/903449686756941824","license":"gnip","citation_ids":[24592814],"posted_on":"2017-09-01T02:49:25+00:00","author":{"name":"Amit_Sharma","image":"https:\/\/pbs.twimg.com\/profile_images\/745153977549881344\/rkck15cI_normal.jpg","description":"Interested in science and      everything else too","id_on_source":"amit_sharma_ind","tweeter_id":"745142458015617024","geo":{"lt":28.63576,"ln":77.22445,"country":"IN"},"followers":117},"tweet_id":"903449686756941824"},{"url":"http:\/\/twitter.com\/ProfSKrishna\/statuses\/903528298352975872","license":"gnip","citation_ids":[24592814],"posted_on":"2017-09-01T08:01:47+00:00","author":{"name":"Sanjeev Krishna","url":"http:\/\/www.tropmed.ac.uk","image":"https:\/\/pbs.twimg.com\/profile_images\/454207346877546496\/ErdL7WcZ_normal.png","description":"Professor Sanjeev Krishna -  Professor of Molecular Parasitology and Medicine at St George\u2019s, University of London - Interests: #Malaria #TB among others.","id_on_source":"ProfSKrishna","tweeter_id":"2207006636","geo":{"lt":null,"ln":null},"followers":622},"tweet_id":"903528298352975872"},{"url":"http:\/\/twitter.com\/Structure_CP\/statuses\/904647095608631296","license":"gnip","rt":["amit_sharma_ind"],"citation_ids":[24592814],"posted_on":"2017-09-04T10:07:29+00:00","author":{"name":"Structure","url":"http:\/\/www.cell.com\/structure\/home","image":"https:\/\/pbs.twimg.com\/profile_images\/2499652168\/structure_128_normal.png","description":"Structure is once monthly publication of @CellPressNews dedicated to research at the cutting edge of #structuralbiology. Tweets are by Editor, @MilkaKostic.","id_on_source":"Structure_CP","tweeter_id":"755404722","geo":{"lt":42.3751,"ln":-71.10561,"country":"US"},"followers":2526},"tweet_id":"904647095608631296"},{"url":"http:\/\/twitter.com\/dkubhi\/statuses\/904755675384840192","license":"gnip","rt":["amit_sharma_ind"],"citation_ids":[24592814],"posted_on":"2017-09-04T17:18:57+00:00","author":{"name":"Devinder Ubhi, PhD","image":"https:\/\/pbs.twimg.com\/profile_images\/831009630327181312\/0VuCj53P_normal.jpg","description":"Protein Scientist chasing knowledge & drug discovery","id_on_source":"dkubhi","tweeter_id":"2750540533","geo":{"lt":37.65466,"ln":-122.40775,"country":"US"},"followers":69},"tweet_id":"904755675384840192"},{"url":"http:\/\/twitter.com\/kfreybiochem\/statuses\/904776741989777408","license":"gnip","rt":["amit_sharma_ind"],"citation_ids":[24592814],"posted_on":"2017-09-04T18:42:39+00:00","author":{"name":"Kathleen Frey","url":"https:\/\/sites.google.com\/view\/kfreyliupharm\/home","image":"https:\/\/pbs.twimg.com\/profile_images\/898620968523923456\/TJSl4_MH_normal.jpg","description":"Assistant Professor with molecular recognition\nhttps:\/\/www.researchgate.net\/profile\/Kathleen_Frey\/info","id_on_source":"kfreybiochem","tweeter_id":"898619986742173697","geo":{"lt":null,"ln":null},"followers":19},"tweet_id":"904776741989777408"},{"url":"http:\/\/twitter.com\/MalariaPapers\/statuses\/905007835368579072","license":"gnip","citation_ids":[24592814],"posted_on":"2017-09-05T10:00:56+00:00","author":{"name":"Malaria Papers","image":"https:\/\/pbs.twimg.com\/profile_images\/633328476070785024\/zGKHLt0g_normal.png","description":"I'm a bot tweeting papers about malaria as they appear on PubMed (& now preprints on BioRxiv). \n\nRun by @theosanderson.","id_on_source":"MalariaPapers","tweeter_id":"3428446343","geo":{"lt":null,"ln":null},"followers":144},"tweet_id":"905007835368579072"},{"url":"http:\/\/twitter.com\/NDM_Papers\/statuses\/905080471410769920","license":"gnip","citation_ids":[24592814],"posted_on":"2017-09-05T14:49:34+00:00","author":{"name":"NDMPapers","image":"https:\/\/pbs.twimg.com\/profile_images\/507495125644083200\/j8GiRQJd_normal.jpeg","description":"RSS feed from PubMed, that shows the most recent scientific papers from the Nuffield Department of Medicine, University of Oxford. Refreshes daily.","id_on_source":"NDM_Papers","tweeter_id":"2789684485","geo":{"lt":null,"ln":null},"followers":105},"tweet_id":"905080471410769920"},{"url":"http:\/\/twitter.com\/OxDrugDes\/statuses\/905098008995516416","license":"gnip","citation_ids":[24592814],"posted_on":"2017-09-05T15:59:15+00:00","author":{"name":"Oxford Drug Design","url":"http:\/\/oxforddrugdesign.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/876762181018292225\/lSK4_9AW_normal.jpg","description":"A drug-discovery company focusing on anti-infectives","id_on_source":"OxDrugDes","tweeter_id":"818390236040429569","geo":{"lt":51.75222,"ln":-1.25596,"country":"GB"},"followers":68},"tweet_id":"905098008995516416"},{"url":"http:\/\/twitter.com\/OxDrugDes\/statuses\/908670190174507008","license":"gnip","citation_ids":[24592814],"posted_on":"2017-09-15T12:33:50+00:00","author":{"name":"Oxford Drug Design","url":"http:\/\/oxforddrugdesign.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/876762181018292225\/lSK4_9AW_normal.jpg","description":"A drug-discovery company focusing on anti-infectives","id_on_source":"OxDrugDes","tweeter_id":"818390236040429569","geo":{"lt":51.75222,"ln":-1.25596,"country":"GB"},"followers":68},"tweet_id":"908670190174507008"},{"url":"http:\/\/twitter.com\/vituljain\/statuses\/910613809617936386","license":"gnip","rt":["amit_sharma_ind"],"citation_ids":[24592814],"posted_on":"2017-09-20T21:17:05+00:00","author":{"name":"vitul jain","url":"http:\/\/www.linkedin.com\/in\/vituljain123","image":"https:\/\/pbs.twimg.com\/profile_images\/700737495332327424\/-oSRdGFN_normal.jpg","description":"Admirer of All Things Natural....Working in Structural biology at Oxford University          https:\/\/www.researchgate.net\/profile\/Vitul_Jain","id_on_source":"vituljain","tweeter_id":"109818893","geo":{"lt":51.75222,"ln":-1.25596,"country":"GB"},"followers":73},"tweet_id":"910613809617936386"}],"blogs":[{"title":"Targeting Prolyl-tRNA Synthetase","url":"http:\/\/toxoplasmaparasite.blogspot.com\/2017\/09\/targeting-prolyl-trna-synthetase.html","license":"public","citation_ids":[24592814,24592814,24592814,24592814,24592814,24592814,24592814,24592814,24592814,24592814,24592814,24592814,24592814,24592814,24592814],"posted_on":"2017-09-05T12:57:00+00:00","summary":"Structure. 2017 Aug 24. pii: S0969-2126(17)30249-6. doi: 10.1016\/j.str.2017.07.015. [Epub ahead of print]Targeting Prolyl-tRNA Synthetase to Accelerate Drug Discovery against Malaria, Leishmaniasis, Toxoplasmosis, Cryptosporidiosis, and CoccidiosisJain V1,","author":{"name":"The Toxoplasma Blog","url":"http:\/\/toxoplasmaparasite.blogspot.com\/","description":"Up to date information and news regarding the protozoan parasite <i>Toxoplasma gondii<\/i>"}}],"facebook":[{"title":"Targeting Prolyl-tRNA Synthetase to Accelerate Drug Discovery against Malaria, Leishmaniasis, Toxoplasmosis, Cryptosporidiosis, and Coccidiosis","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=1206861852748477&id=100549596713047","license":"public","citation_ids":[24592814],"posted_on":"2017-09-06T12:12:46+00:00","summary":"Synthesis and enzyme inhibition in multiple parasites, described by Jain et\u00a0al., provides a new facet to quinazolinone-based inhibitors (QBIs). Multi-parasite drugging studies, coupled with structures of protein-drug complexes, reveal structural basis of Q","author":{"name":"GEPAMOL","url":"https:\/\/www.facebook.com\/100549596713047","facebook_wall_name":"GEPAMOL","image":"https:\/\/graph.facebook.com\/100549596713047\/picture","id_on_source":"100549596713047"}}]}}